What's happening now

Daiichi Sankyo gets approval of its first oncology product in the US.

Our Legacy in the U.S.

Daiichi Sankyo is Chair of the Centennial Host Committee for the 2012 National Cherry Blossom Festival.

A passion for innovation

A passion for innovation.

The Daiichi Sankyo Group includes an international network of affiliates focused on the regional commercialization of our pharmaceutical products. This network is in addition to drug discovery and clinical development operations around the globe.

Headquartered in Edison, New Jersey, Daiichi Sankyo Pharma Development (DSPD) is responsible for the regional delivery of global clinical trials.  Our highly skilled staff develop and manage clinical trials conducted in North, South and Central America and submit product applications to the local health authorities.

Our pursuit of new medicines is fueled by the relentless scientific curiosity of our employees, a willingness to examine new ideas and the pairing of existing information with novel concepts. We innovate by creating new medicines, as well as new methods of drug discovery and delivery. Daiichi Sankyo is constantly developing, deepening and broadening our pipeline to address unmet medical needs.

Innovation is integral to the mission that drives us today, and to the vision that defines our future.  To learn more about our history of innovation and our visiion to join the fight against cancer, click here.

Contact information

Daiichi Sankyo Pharma Development
399 Thornall Street
Edison, NJ 08837
Phone: 732-590-5000

Product Pipeline
Product Pipeline

An ever-expanding portfolio of promising new
compounds.

Learn More...